Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 7th In-House Impact: Biopharma Summit.

Early Stage Biotechs
Growth Stage Biotechs
Commercial Stage Biopharma
Industry & Strategic Experts

Early Stage Biotechs

Iya Kessler

General Counsel & Corporate Secretary
Arbor Biotechnologies, Inc.
Jessica Oien

Jessica Oien

Chief Legal Officer, Head of Quality & Corporate Secretary
Boundless Bio

Barbara McClung

Chief Legal Officer
Caribou Biosciences, Inc.

Kady Bruce

Head of Intellectual Property
Crescent Biopharma

Jenny Robertson

Formerly Chief Legal Officer
Lexeo Therapeutics
Rachel Herder

Rachel Herder

SVP, Legal & Alliance Management (Head of IP)
Mammoth Biosciences

Growth Stage Biotechs

Jeff Cohn

General Counsel and Corporate Secretary
Connect Biopharma

Rahul Khara

Chief Legal Officer
Disc Medicine

Jason Tejani

General Counsel & Corporate Secretary 
Enveda Therapeutics, Inc.

Curt oltmans

CLO
Fulcrum Therapeutics

Agustina Imfeld

Chief Legal Officer
Gameto

Nicole Clouse

Vice President Head of Intellectual Property
Generate Biomedicines, Inc

Michael Bookman

Chief Legal Officer & Secretary
Immuneering Corp.

Shawnte Mitchell

Chief Legal Officer & Corporate Secretary
Olema Oncology

Teresa Jurgensen

Executive Vice President, General Counsel
Parabilis Medicines

Jennifer Fitzpatrick

Chief Legal Officer
Sionna Therapeutics

Commercial Stage Biopharma

James Fraser

Assistant General Counsel, Commercial Legal Lead (N. America)
BeOne Medicines

Christopher Slavinsky

Formerly General Counsel & Head of Compliance
Corstasis Therapeutics

Jeff Burris

Chief Legal Officer
Indivior Plc.

Jim Pepin

General Counsel
Legend Biotech

Gillian Woollett

VP, Regulatory Strategy and Policy
Samsung Bioepis

Daryl Kreml

Head of Ethics & Compliance
Takeda Pharmaceutical

Industry & Strategic Experts

Julia Lifshits

Assistant General Counsel
Beckman Coulter Inc.

TJ Cradick

Principal & Fractional CSO
Gene Editing Frontiers

Jonathan Wilkenfeld

President
Potomac River Partners
Networking-Image-4

Explore the Agenda

Discover the strategies biopharma GCs are using to navigate FDA shifts, pricing reform, AI governance and crossborder risk across two focused days of curated sessions. 

View Presentations & Speakers
1-768x432

Partner With Us

Showcase your expertise to the in-house community and position your brand as a trusted partner shaping biopharma legal strategy in 2026. 

Explore Sponsorship Options
Speakers Image (2)

Join Biopharma Legal Leaders

Connect with senior in-house counsel from leading biotechs and pharmaceutical companies during highvalue networking designed for meaningful GCtoGC exchange. 

Register Now